| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/09/2003 | WO2003002741A2 Nucleic acids encoding nuclear receptors |
| 01/09/2003 | WO2003002739A1 Antisense oligonucleotide against human acetylcholinesterase (ache) and uses thereof |
| 01/09/2003 | WO2003002738A1 Methods and materials for generating genetic disruptions in bacterial cells |
| 01/09/2003 | WO2003002736A2 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | WO2003002735A2 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
| 01/09/2003 | WO2003002734A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002727A2 Hammerhead ribozyme specific for the stearoyl-acp desaturrase of different oleaginous plants |
| 01/09/2003 | WO2003002726A2 Cellular reporter gene assay with a ligand amplifying feedback loop |
| 01/09/2003 | WO2003002725A1 Gene targeting methods and vectors |
| 01/09/2003 | WO2003002723A2 Mating-based method for detecting protein-protein interaction |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002721A2 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | WO2003002719A2 Isoform of castor oleate hydroxylase |
| 01/09/2003 | WO2003002716A2 Polymer stabilized proteinases |
| 01/09/2003 | WO2003002714A2 Protein tyrosine phosphatase 2 gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003002713A2 Antibodies to opgl |
| 01/09/2003 | WO2003002711A2 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 01/09/2003 | WO2003002709A2 Novel technology for genetic mapping |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002608A1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 01/09/2003 | WO2003002607A1 Reducing immunogenicities of immunoglobulins by framework-patching |
| 01/09/2003 | WO2003002606A2 Nucleic acids encoding ion channels |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002597A2 Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein |
| 01/09/2003 | WO2003002592A1 Aptamers and antiaptamers |
| 01/09/2003 | WO2003002155A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 01/09/2003 | WO2003002154A1 Artificial autologous skin secreting leptin and method for obtaining the same |
| 01/09/2003 | WO2003002146A1 Medicinal compositions |
| 01/09/2003 | WO2003002144A1 Bispecific antibodies that bind to vegf receptors |
| 01/09/2003 | WO2003002143A1 A novel engineered superantigen for human therapy |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002114A2 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 01/09/2003 | WO2003002069A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/09/2003 | WO2003002065A2 Hcv e1e2 vaccine compositions |
| 01/09/2003 | WO2003001908A1 Hspc150-like gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003001907A1 Nmp35 apoptosis inhibitor gene disruptions compositions and methods related thereto |
| 01/09/2003 | WO2003001902A2 Alteration of oil traits in plants |
| 01/09/2003 | WO2003001901A2 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 01/09/2003 | WO2003001900A2 Process of controlled shuffling of chromosome fragments for plant breeding |
| 01/09/2003 | WO2003001883A2 Gaba b1a receptor disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001882A2 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001881A2 Cell-based high-throughput screening methods |
| 01/09/2003 | WO2003001877A2 Methods for the diagnosis and treatment of cardiac tissue rejection |
| 01/09/2003 | WO2003001876A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | WO2003001863A2 Novel endothelially expressed dnas and proteins, and their use |
| 01/09/2003 | WO2002095035A8 Crystal structure of ketopantoate reductase and use thereof |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |
| 01/09/2003 | WO2002090491A3 Modification of metal-handling in plants |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002072789A9 Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters |
| 01/09/2003 | WO2002066651A3 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum |
| 01/09/2003 | WO2002063014A3 Human tyrosine-specific protein phosphatase |
| 01/09/2003 | WO2002062144A3 Method for controlling harmful organisms in the culture of useful plants |
| 01/09/2003 | WO2002059558A3 Means and methods for treatment evaluation |
| 01/09/2003 | WO2002055658A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/09/2003 | WO2002048335A9 Metal resistant plants and use for phytoremediation |
| 01/09/2003 | WO2002048189A3 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 01/09/2003 | WO2002046444A3 Double transposition methods for manipulating nucleic acids |
| 01/09/2003 | WO2002046423A3 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines |
| 01/09/2003 | WO2002046399A3 Mutated class i major histocompatibility proteins and complexes |
| 01/09/2003 | WO2002046373A9 Method of collecting placental stem cells |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002040685A3 Vectors for conditional gene inactivation |
| 01/09/2003 | WO2002038774A3 Bacterial phytases and method for producing same |
| 01/09/2003 | WO2002038769A3 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 |
| 01/09/2003 | WO2002038743A3 Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| 01/09/2003 | WO2002036793A3 Secreted protein associated with depression; composition and methods of use thereof |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002031142A3 Antisense nucleic acid against alphav integrin |
| 01/09/2003 | WO2002029039A3 47316, a novel human g-protein and uses therefor |
| 01/09/2003 | WO2002028175A3 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 01/09/2003 | WO2002026997A3 Dsp-16 dual-specificity phosphatase |
| 01/09/2003 | WO2002026967A3 Targeted gene correction by single-stranded oligodeoxynucleotides |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002022779A3 High level expression of heterologous proteins |
| 01/09/2003 | WO2002018569A3 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 01/09/2003 | WO2002016655A9 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2002013855A3 Vaccines containing ribavirin and methods of use thereof |
| 01/09/2003 | WO2002012526A3 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |
| 01/09/2003 | WO2002012327A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 01/09/2003 | WO2002012282A3 Novel ebi-3-alt protein and nucleic acid molecules and uses therefor |
| 01/09/2003 | WO2002011756A3 Anti-plasmodium compositions and methods of use |
| 01/09/2003 | WO2002010203A3 Daz genes |
| 01/09/2003 | WO2002008428A3 Production of polyhydroxyalkanoates from polyols |
| 01/09/2003 | WO2002008407A3 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/09/2003 | WO2002008283A3 Lp120 polypeptides and therapeutic uses thereof |
| 01/09/2003 | WO2002006461A3 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 01/09/2003 | WO2002004670A3 Improved capture and detection of target nucleic acid in dipstick assays |
| 01/09/2003 | WO2002004518A3 Human neuropeptide y-like g protein-coupled receptor |
| 01/09/2003 | WO2002004510A3 Gtp-binding proteins |
| 01/09/2003 | WO2002002766A3 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/09/2003 | WO2002002605A3 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/09/2003 | WO2002000697A3 Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis |